Home » Posts tagged 'fenr'

Tag Archives: fenr

Solid trading from Aveva and Fenner – yet another placing from blur Group

AVEVA Group AVV reports a solid start to the financial year and expects the phasing of revenue in FY 2018 to be broadly similar to the prior year. The full year outlook remains in line with board expectations.

blur Group BLUR announces yet another placing to raise a minimum of £1.5m (before expenses) at 1.75 pence per Ordinary Share.

Dunelm DNLM provides a year end trading update, and says total Q4 revenue rose by 17.7% to £240.0m, with total like-for-like growth (combining LFL stores and Home Delivery) up 3.8%. CEO John Browett said the Worldstores acquisition “will provide a massive leap forward to our online and store offer that we think our customers will love.”

Fenner FENR updates on trading and continues to make strong progress, principally in new product development, augmented by a further increase in the US rig count. Cash flow during the period has remained in line with expectations and, on the basis of the improved outlook, most notably in the medical businesses, the Board anticipates that the Group’s operating profit for the financial year ending 31 August 2017 will be comfortably ahead of its previous expectations, with the added benefit of a reduced interest charge going forward.

Portmeirion PMP says total Group sales are up 16% for the six months ended 30 June 2017 relative to the same period last year, and it continues to expect profit before tax to be in line with market expectations for the full year.

Scholium Group SCHO the rare books and art company reported full year revenues of £6.12m (2016: £6.74m) and an adjusted operating loss of £224k (2016: £24k profit). Although the result was poor, Scholium recorded a turnaround to profitability during H2 once the uncertainty around the UK Referendum lifted. Following cost savings, CEO Jasper Allen said Scholium was now “well-placed to deliver a positive outcome.”

Fenner In Recovery Mode

Fenner FENR now expects results for the current year will be comfortably ahead of previous expectations as a result of gains in market share and refocusing of the businesses. These factors have helped to create an improving trend in order intake and a stronger market position in the US. Australia is doing well and results are ahead of last year.

Crawshaw Group CRAW With like for like sales down by 3.8% for the 5 weeks from 29th November to 31st December and like for like customer numbers down by 4.2%, Crawshaw claims that it has continued to build on previous progress, presumably wishing to rely for justification of its claim that total sales and customer numbers for the same period both rose by 13%. At least the figures for the 5 week Christmas period showed  an improvement on the previous 4 weeks like for like figures when sales had slumped by 8.1% and customer numbers by 9.7%.

Gear4music G4M enjoyed a strong sales performance in the last 4 months of the year and full year profits are now expected to be ahead of the increase indicated at the half year stage. UK sales rose by 29%, Europe and the rest of the world by by 129% and total sales by 55%.  For the year to date growth has totaled 63%.

easyJet EZJ With December traffic figures up by 15.1% easyJet is not allowing itself to be left behind by Ryanair. The rise in load factor at 3.3% was also similar to that of its competitor, although over the rolling 12 month period, load factor did slip slightly by 0.1pp

Sky plc SKY Broker Investec has upgraded its investment rating on Sky plc SKY from reduce to hold and has raised its price target from 800p to 1075p.

Next NXT has suffered from yesterdays results with Citigroup cutting its price target from 4,800p to 4,100p

New Year Promise ? Buy a villa in Greece this year – visit;   http://www.hiddengreece.net

Daily Actions – UK Main & AIM markets 18012016

IntellisysLogoDaily Actions is a daily summary analysis of changes in short term actions from our Daily Recs – AIM and Daily Recs Main markets reports. This report is typically distributed before the open of trading in London.

AIM Market

ST Rec. changed
From To
Chemicals
Byotrol Buy Neutral
Plant Healthcare Neutral Buy
Financial Services
ADVFN Strong Buy Buy
Zoltav Resources Buy Neutral
Tiziana Life Sciences Neutral Buy
Industrial Good & Services
James Latham Neutral Sell
Kennedy Ventures Buy Neutral
Yolo Leisure & Technology Neutral Buy
Synectics Neutral Sell
Media
Mirada Neutral Buy
Oil & Gas – Explorers
Independent Resources Strong Buy Buy
Oil & Gas – Producers
Plexus Holdings Strong Buy Neutral
President Petroleum Neutral Buy
Technology
1Spatial Buy Neutral
NetDimensions Holdings Sell Neutral
Zoo Digital Group Buy Neutral

 

Main Market

ST Rec. changed
From To
Banks
Lloyds Banking Group Neutral Buy
Beverages
SAB Miller Neutral Sell
Heavy Construction
Henry Boot Neutral Sell
Engineering & Machinery
Castings Sell Neutral
Fenner Neutral Buy
Hill & Smith Neutral Sell
Food Producers & Processors
Cranswick Neutral Sell
Unilever (UK) Neutral Sell
Household Goods & Textiles
Headlam Group Neutral Sell
Leisure & Hotels
Mitchells & Butlers Buy Neutral
Restaurant Group Buy Neutral
Life Assurance
Chesnara Sell Neutral
Media & Entertainment
Informa Neutral Sell
St. Ives Neutral Sell
Personal Care & Household Products
Reckitt Benckiser Group Neutral Sell
Real Estate – REIS
J Smart Neutral Sell
Support Services
Aggreko Neutral Buy
Compass Group Neutral Sell
Michael Page International Buy Neutral
Rexam Neutral Sell
Telecommunication Services
BT Group Neutral Sell
Utilities
National Grid Neutral Sell

RISK WARNING

Intellisys Intelligent Analysis Limited (‘Intellisys’) does not make personal recommendations. The information in this publication is provided solely to enable you to make your own investment decisions. If you are unsure about dealing in shares and other equity investments, you must contact your financial adviser as these types of investments may not be suitable for everyone. The value of stocks and shares, and the income from them, can fall as well as rise and you may not get back the full amount you originally invested. If denominated in a foreign currency, fluctuations in the exchange rate will also affect the value of stocks and shares and the income from them. Past performance is not necessarily a guide to future performance. You agree to abide fully with Intellisys’ Term & Conditions, which are available to www.intellisys.uk.com

The full reports are available from Intellisys Intelligent Analysis website (www.intellisys.uk.com) by clicking on the ‘Research’ tab.

DISCLAIMER: Intellisys Intelligent Analysis Limited has prepared this report. Intellisys (“Intellisys”) is the trading name of Intellisys Intelligent Analysis Limited. Intellisys Intelligent Analysis Limited is a provider of financial research reports that indicate the possible value of quoted company shares. The information contained within any and all of Intellisys’ reports are designed to present an objective assessment of the possible value or relative value of a company and/or an actuarial sector or stock market index. Intellisys utilises as extensive as possible range of valuation tools and proprietary systems to derive its outputs. The base data for the models are derived from sources believed to be accurate but Intellisys Intelligent Analysis Limited does not warrant or guarantee the accuracy or reliability of the source data or its models and proprietary systems. Subscribers, and casual readers, should not rely upon the Intellisys’ research outputs when forming specific investment decisions but should seek advice specific to their situation and investment requirements from a person authorised under the Financial Services and Markets Act 2000, before entering into any investment agreement.Intellisys Intelligent Analysis Limited has used reasonable care and skill in compiling the content of this report. No representation or warranty, expressed or implied, is given by any person as to the accuracy or completeness or accuracy of the information and no responsibility or liability is accepted to the accuracy or sufficiency of any of the information, for any errors, omissions or misstatements, negligent or otherwise. In no event will Intellisys Intelligent Analysis Limited, Intellisys or any of its officers, employees or agents be liable to any other party for any direct, indirect, special or other consequential damages arising from the use of this report.

The Intellisys Intelligent Analysis Limited and/or Intellisys reports are not directed to any person in any jurisdiction where (by reason of that person’s nationality, residence or otherwise) the publication or availability of the Intellisys Intelligent Analysis Limited and/or Intellisys information may be prohibited. Persons in respect of whom such prohibitions apply must not access the Intellisys Intelligent Analysis Limited and/or Intellisys reports. Neither this document, nor any copy in whatever form of media, may be taken or transmitted into the United States, Canada, Australia, Ireland, South Africa or Japan or into any jurisdiction where it would be unlawful to do so. Any failure to comply with this restriction may constitute a violation of relevant local securities laws. Recipients of Intellisys Intelligent Analysis Limited and/or Intellisys reports outside the UK are not covered by the rules and regulations made for the protection of investors in the UK.

Any user distributing information taken from any Intellisys Intelligent Analysis Limited or Intellisys report and/or the Intellisys website, in whatever form, to any other person, agrees to attach a copy of this Disclaimer and the Terms and Conditions of Use pages and obtain the agreement of such other person to comply with the terms set forth.

Intellisys’ published reports are published for information purposes and only available to market counterparties, high net-worth and sophisticated individual investors.

No Intellisys report constitutes an offer or invitation to trade, sell, purchase or acquire any shares or other financial instruments in any company or any interest therein, nor shall it form the basis of any contract entered into for the sale of shares or any other financial instrument in any company.

Intellisys Intelligent Analysis Limited believes that the information within each and any of its reports to be correct, but its accuracy or completeness cannot be guaranteed. No representation or warranty, expressed or implied, is given by any person as to the accuracy or completeness of the information and no responsibility or liability is accepted for the accuracy or sufficiency of any of the information, for any errors, omissions or mis-statements, negligent or otherwise.

Intellisys Intelligent Analysis Limited (including its Directors, employees and representatives) or a connected person may have positions in or options or other financial instruments on any of the securities mentioned within a report, and may buy, sell or offer to purchase or sell such securities from time to time, subject to restrictions imposed by internal rules.

Subscribers, and casual reader, are reminded that the value of any financial instrument may go up or down and that past performance is not necessarily a guide to future performance.

Intellisys Intelligent Analysis Limited is not registered with or regulated by any financial regulatory authority and does not offer, provide or purport to provide or offer investment advice. Intellisys Intelligent Analysis Limited can be contacted at Woodfield Cottage, The Street, Mortimer, Berkshire, United Kingdom RG7 3DW.

 

I would like to receive Brand Communications updates and news...
Free Stock Updates & News
I agree to have my personal information transfered to MailChimp ( more information )
Join over 3.000 visitors who are receiving our newsletter and learn how to optimize your blog for search engines, find free traffic, and monetize your website.
We hate spam. Your email address will not be sold or shared with anyone else.